title: [Dyslipidaemia and diabetes mellitus].
abstract: Cardiovascular diseases are the main complications in diabetes. The lipid pattern includes high triglycerides, low HDL and increased small dense LDL. The treatment strategy is based upon the European Guidelines which insist on global risk evaluation and recommend more severe lipid targets for diabetic than for non diabetic patients. After changes of lifestyle and control of risk factors, statins or fibrates are the drugs of choice, even if fibrates have specific impact on patients with diabetes or the metabolic syndrome.
authors: CHU Tivoli, La Louvière. jean.ducobu@chu-tivoli.be
authors: J
authors: J
authors: Ducobu
mesh_terms: D002995:Clofibric Acid / Q000627:therapeutic use; D048909:Diabetes Complications / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology*; D008019:Life Style; D012307:Risk Factors
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002995:Clofibric Acid